These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 9733667

  • 1. Comparative pharmacokinetics of oral and intravenous ifosfamide/mesna/methylene blue therapy.
    Aeschlimann C, Küpfer A, Schefer H, Cerny T.
    Drug Metab Dispos; 1998 Sep; 26(9):883-90. PubMed ID: 9733667
    [Abstract] [Full Text] [Related]

  • 2. Urine mesna excretion after intravenous and oral dosing in ifosfamide-treated children.
    Goren MP, Epelman S, Bush DA.
    Cancer Chemother Pharmacol; 2004 Sep; 54(3):237-40. PubMed ID: 15184993
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A phase I study of prolonged ambulatory infusion of Ifosfamide with oral mesna.
    Olver I, Keefe D, Myers M, Caruso D.
    Chemotherapy; 2005 May; 51(2-3):142-6. PubMed ID: 15886474
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of (mono)amine oxidase activity and prevention of ifosfamide encephalopathy by methylene blue.
    Aeschlimann C, Cerny T, Küpfer A.
    Drug Metab Dispos; 1996 Dec; 24(12):1336-9. PubMed ID: 8971139
    [Abstract] [Full Text] [Related]

  • 12. Etoposide pharmacokinetics and survival in patients with small cell lung cancer: a multicentre study.
    You B, Tranchand B, Girard P, Falandry C, Ribba B, Chabaud S, Souquet PJ, Court-Fortune I, Trillet-Lenoir V, Fournel C, Tod M, Freyer G.
    Lung Cancer; 2008 Nov; 62(2):261-72. PubMed ID: 18442869
    [Abstract] [Full Text] [Related]

  • 13. High-dose ifosfamide with mesna and granulocyte-colony-stimulating factor (recombinant human G-CSF) in patients with unresectable malignant mesothelioma.
    Talbot SM, Rankin C, Taub RN, Balcerzak SP, Bhoopalam N, Chapman RA, Baker LH, Middleman EL, Antman KH.
    Cancer; 2003 Jul 15; 98(2):331-6. PubMed ID: 12872353
    [Abstract] [Full Text] [Related]

  • 14. Hydration, methylene blue, and thiamine as a prevention regimen for ifosfamide-induced encephalopathy.
    Gharaibeh EZ, Telfah M, Powers BC, Salacz ME.
    J Oncol Pharm Pract; 2019 Oct 15; 25(7):1784-1786. PubMed ID: 30348070
    [Abstract] [Full Text] [Related]

  • 15. DICE (dexamethasone, ifosfamide, cisplatin, etoposide) infusional chemotherapy for refractory or relapsed non-Hodgkin's lymphoma (NHL).
    Coleman M, Leonard J, Shuster MW, Kaufman TP.
    Eur J Haematol Suppl; 2001 Jul 15; 64():41-5. PubMed ID: 11486401
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Ifosfamide- and etoposide-based chemotherapy as salvage and mobilizing regimens for poor prognosis lymphoma.
    Mayer J, Vásová I, Korístek Z, Navrátil M, Klabusay M, Doubek M, Vorlícek J, Cernilová I, Vodvárka P, Petráková K.
    Eur J Haematol Suppl; 2001 Jul 15; 64():21-7. PubMed ID: 11486396
    [Abstract] [Full Text] [Related]

  • 18. Phase II study of induction chemotherapy with paclitaxel, ifosfamide, and carboplatin (TIC) for patients with locally advanced squamous cell carcinoma of the head and neck.
    Shin DM, Glisson BS, Khuri FR, Lippman SM, Ginsberg L, Diaz E, Papadimitrakopoulou V, Feng L, Francisco M, Garden A, Kies MS, Myers J, Clayman G, Hong WK.
    Cancer; 2002 Jul 15; 95(2):322-30. PubMed ID: 12124833
    [Abstract] [Full Text] [Related]

  • 19. Combined intravenous and oral mesna in outpatients treated with ifosfamide.
    Goren MP, McKenna LM, Goodman TL.
    Cancer Chemother Pharmacol; 1997 Jul 15; 40(5):371-5. PubMed ID: 9272112
    [Abstract] [Full Text] [Related]

  • 20. Pharmacokinetics of cyclophosphamide and thiotepa in a conventional fractionated high-dose regimen compared with a novel simplified unfractionated regimen.
    Ekhart C, Rodenhuis S, Beijnen JH, Huitema AD.
    Ther Drug Monit; 2009 Feb 15; 31(1):95-103. PubMed ID: 19155964
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.